Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Afina M
    Junior Member
    • May 2021
    • 1

    #1

    16S V4 reads contain high % reverse primer

    Hi everyone,

    I am running BI analysis for 16S V4 samples that was run using 515F/806R, MiSeq 300 PE. In average, all samples have more than 200k reads.

    I run bduk below to remove the primers and more than 90% reads are trimmed out which only left 20k reads which I find it weird. I checked the stats output from bbduk and all samples contains really high % of reverse primer.

    Code:
    bbduk.sh in1=${SAMPLE}_R1_001.fastq.gz in2=${SAMPLE}_R2_001.fastq.gz \
    		out1=ra_${SAMPLE}_R1.fastq out2=ra_${SAMPLE}_R2.fastq \
    		ktrim=l k=$numk mink=$mink copyundefined=t \
    		literal="GTGCCAGCMGCCGCGGTAA,GGACTACHVGGGTWTCTAAT" hdist=1 stats=${SAMPLE}_stats.txt \
    		tpe tbo
    Can anyone help to advice if this is normal? I run the tool multiple time with another 16S V4 dataset and the same thing happened. I did compare with 16S V3-V4 dataset and it only has around 40-50% primers.

    I am still not really familiar with sequencing workflow so can anyone help me how to check this?

    Thank you.
    Last edited by Afina M; 05-18-2021, 07:15 PM.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    Yesterday, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 05:39 AM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 09-29-2026, 09:51 AM
0 responses
77 views
0 reactions
Last Post SEQadmin2  
Working...